Transient neutropenia induced by intravenous immune globulin

Eldad Ben-Chetrit, Chaim Putterman, Mark D. Grebenau

Research output: Contribution to journalLetterpeer-review

57 Scopus citations


To the Editor: Intravenous immune globulin is used as an immunomodulatory agent in various autoimmune diseases.1 Adverse effects are uncommon but may include vasomotor symptoms such as chills, nausea, flushing, tightness of the chest, and wheezing.2 Hemolysis, thrombosis, alopecia, and liver-function disturbances have also been reported.3 4 5 Recently, we encountered a 36-year-old woman with active systemic lupus erythematosus in whom treatment with prednisone (60 mg daily) and azathioprine (200 mg daily) had failed to control the manifestations of the disease. Therefore, we decided to attempt a trial of immune globulin (Sandoglobulin, Sandoz), given in two courses (400 mg per kilogram of. . .

Original languageEnglish
Pages (from-to)270-271
Number of pages2
JournalNew England Journal of Medicine
Issue number4
StatePublished - 23 Jan 1992
Externally publishedYes


Dive into the research topics of 'Transient neutropenia induced by intravenous immune globulin'. Together they form a unique fingerprint.

Cite this